1. Home
  2. GOSS vs HELE Comparison

GOSS vs HELE Comparison

Compare GOSS & HELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • HELE
  • Stock Information
  • Founded
  • GOSS 2015
  • HELE 1968
  • Country
  • GOSS United States
  • HELE United States
  • Employees
  • GOSS N/A
  • HELE N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • HELE Home Furnishings
  • Sector
  • GOSS Health Care
  • HELE Consumer Discretionary
  • Exchange
  • GOSS Nasdaq
  • HELE Nasdaq
  • Market Cap
  • GOSS 585.9M
  • HELE 474.4M
  • IPO Year
  • GOSS 2019
  • HELE N/A
  • Fundamental
  • Price
  • GOSS $2.41
  • HELE $19.73
  • Analyst Decision
  • GOSS Strong Buy
  • HELE Hold
  • Analyst Count
  • GOSS 6
  • HELE 3
  • Target Price
  • GOSS $8.60
  • HELE $42.00
  • AVG Volume (30 Days)
  • GOSS 3.7M
  • HELE 1.1M
  • Earning Date
  • GOSS 11-06-2025
  • HELE 10-09-2025
  • Dividend Yield
  • GOSS N/A
  • HELE N/A
  • EPS Growth
  • GOSS N/A
  • HELE N/A
  • EPS
  • GOSS N/A
  • HELE N/A
  • Revenue
  • GOSS $40,237,000.00
  • HELE $1,820,033,000.00
  • Revenue This Year
  • GOSS N/A
  • HELE N/A
  • Revenue Next Year
  • GOSS $34.10
  • HELE $3.14
  • P/E Ratio
  • GOSS N/A
  • HELE N/A
  • Revenue Growth
  • GOSS N/A
  • HELE N/A
  • 52 Week Low
  • GOSS $0.66
  • HELE $19.05
  • 52 Week High
  • GOSS $3.60
  • HELE $75.68
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 44.51
  • HELE 35.19
  • Support Level
  • GOSS $2.25
  • HELE $19.05
  • Resistance Level
  • GOSS $2.61
  • HELE $20.96
  • Average True Range (ATR)
  • GOSS 0.18
  • HELE 1.38
  • MACD
  • GOSS -0.05
  • HELE -0.69
  • Stochastic Oscillator
  • GOSS 24.58
  • HELE 5.32

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

Share on Social Networks: